Your browser doesn't support javascript.
loading
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.
Stupp, R; Tosoni, A; Bromberg, J E C; Hau, P; Campone, M; Gijtenbeek, J; Frenay, M; Breimer, L; Wiesinger, H; Allgeier, A; van den Bent, M J; Bogdahn, U; van der Graaf, W; Yun, H J; Gorlia, T; Lacombe, D; Brandes, A A.
Afiliação
  • Stupp R; Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. Electronic address: roger.stupp@chuv.ch.
  • Tosoni A; Department of Medical Oncology, Bellaria Maggiore Hospital, Bologna, Italy.
  • Bromberg JEC; Department of Neuro-Oncology, Daniel den Hoed Cancer Center/Erasmus University Hospital, Rotterdam, The Netherlands.
  • Hau P; Department of Neurology, University of Regensburg Medical School, Regensburg, Germany.
  • Campone M; Department of Medical Oncology, Institut Régional du Cancer Nantes Atlantique, CLCC René Gauducheau, Centre de Recherche en Cancérologie, St Herblain, France.
  • Gijtenbeek J; Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Frenay M; Department of Medical Oncology, Centre Antoine Lacassagne, Nice Cedex, France.
  • Breimer L; Bayer Healthcare, Montville, USA.
  • Wiesinger H; Bayer Schering Pharma, Berlin, Germany.
  • Allgeier A; EORTC Headquarters, Brussels, Belgium.
  • van den Bent MJ; Department of Neuro-Oncology, Daniel den Hoed Cancer Center/Erasmus University Hospital, Rotterdam, The Netherlands.
  • Bogdahn U; Department of Neurology, University of Regensburg Medical School, Regensburg, Germany.
  • van der Graaf W; Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Yun HJ; EORTC Headquarters, Brussels, Belgium.
  • Gorlia T; EORTC Headquarters, Brussels, Belgium.
  • Lacombe D; EORTC Headquarters, Brussels, Belgium.
  • Brandes AA; Department of Medical Oncology, Bellaria Maggiore Hospital, Bologna, Italy.
Ann Oncol ; 22(9): 2144-2149, 2011 Sep.
Article em En | MEDLINE | ID: mdl-21321091

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article